Aspire Biopharma (ASBP) announced that Glatt Air Techniques has undertaken FDA-required testing of the Company’s high-dose sublingual aspirin ...
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback